Detailed answers about OXFORD TARGET THERAPEUTICS LIMITED, including incorporation, status, business activity, and accounts information.
When was OXFORD TARGET THERAPEUTICS LIMITED founded?
OXFORD TARGET THERAPEUTICS LIMITED was officially incorporated on 2 February 2022 and is registered under company number 13886983. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is OXFORD TARGET THERAPEUTICS LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of OXFORD TARGET THERAPEUTICS LIMITED?
OXFORD TARGET THERAPEUTICS LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does OXFORD TARGET THERAPEUTICS LIMITED do?
OXFORD TARGET THERAPEUTICS LIMITED operates in the following sector: 72110 - Research and experimental development on biotechnology. This provides insight into the company's primary business activity and industry focus.
What is OXFORD TARGET THERAPEUTICS LIMITED's registered address?
The registered office address of OXFORD TARGET THERAPEUTICS LIMITED is BIOINNOVATION HUB, TONGE BUILDING OXFORD BROOKES UNIVERSITY, GIPSY LANE, HEADINGTON CAMPUS, OXFORD, OXFORDSHIRE, UNITED KINGDOM, OX3 0BP. This is the official address filed with Companies House for legal and statutory correspondence.
Is OXFORD TARGET THERAPEUTICS LIMITED financially stable?
The most recent accounts for OXFORD TARGET THERAPEUTICS LIMITED were made up to 31 July 2025, filed as TOTAL EXEMPTION FULL. Next accounts are due by 30 April 2027.